Risk of Reoperation Within 90 Days of Liver Transplantation: A Necessary Evil?

J Am Coll Surg. 2016 Apr;222(4):419-28. doi: 10.1016/j.jamcollsurg.2016.01.007. Epub 2016 Jan 23.

Abstract

Background: The rate and consequences of reoperation after liver transplantation (LT) are unknown in the United States.

Study design: Adult patients (n = 10,295; 45% of all LT) undergoing LT from 2009 through 2012 were examined using a linkage of the University HealthSystem Consortium and Scientific Registry of Transplant Recipients databases providing recipient, donor, center, hospitalization, and survival details. Median follow-up was 2 years. Reoperations were identified within 90 days after LT.

Results: Overall 90-day reoperation rate after LT was 29.3%. Risk factors for 90-day reoperation included recipients with a history of hemodialysis, severely ill functional status, government insurance, increasing Model for End-Stage Liver Disease score, and increasing donor risk index. Reoperation within 90 days was found to be an independent predictor of adjusted 1-year mortality (odds ratio = 1.8; 95% CI, 1.5-2.1), as was government-provided insurance and increasing donor risk index. Additionally, patients undergoing delayed reoperative intervention (after 30 days) were found to have increased risk of 1-year mortality compared with those undergoing early reoperative intervention (odds ratio = 1.96; 95% CI, 1.4-2.7; p < 0.01).

Conclusions: This is the first national study reporting that nearly one-third of transplant recipients undergo reoperation within 90 days of LT. Although necessary at times, reoperation is associated with increased risk of death at 1 year; however, it appears that the timing of these interventions can be critical, due to the type of intervention required. Early reoperative intervention does not appear to influence long-term outcomes, and delayed intervention (after 30 days) is strongly associated with decreased survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cohort Studies
  • End Stage Liver Disease / etiology
  • End Stage Liver Disease / mortality*
  • End Stage Liver Disease / surgery*
  • Female
  • Humans
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Odds Ratio
  • Reoperation
  • Risk Factors
  • Survival Analysis
  • Time Factors
  • Treatment Outcome
  • United States / epidemiology
  • Young Adult